Analysis of imatinib and sorafenib binding to p38α Compared with c-Abl and b-Raf provides structural insights for understanding the selectivity of inhibitors targeting the DFG-out form of protein kinases
JavaScript is disabled for your browser. Some features of this site may not work without it.
Analysis of imatinib and sorafenib binding to p38α Compared with c-Abl and b-Raf provides structural insights for understanding the selectivity of inhibitors targeting the DFG-out form of protein kinases
Namboodiri, HV; Bukhtiyarova, M; Ramcharan, J; Karpusas, M; Lee, Y; Springman, EB